Data Tables


Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PA k) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (351 K)



View HTMLView PDF

Section I

1.1U.S. Organ Donors by Organ and Donor Type, 1997 to 2006Table 1.1 (29 k)
1.2Number of Organs Recovered from Deceased Donors, 1997 to 2006Table 1.2 (24 k)
1.3Waiting List at End of Year, 1997 to 2006Table 1.3 (27 k)
1.4Characteristics of Waiting List Patients at End of Year, 1997 to 2006Table 1.4 (36 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Patient Status
1.5Time to Transplant New Waiting List Registrations, 1997 to 2006Table 1.5 (35 k)
1.6Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1997 to 2006Table 1.6 (29 k)
1.7Transplants by Organ and Donor Type, 1997 to 2006Table 1.7 (29 k)
1.8Multi-Organ Transplants, 1997 to 2006Table 1.8 (26 k)
1.9aImmunosuppression Use by Organ in 2005 and 2006Table 1.9a (34 k)
1.9bImmunosuppression Use by Organ Maintenance Regimen at Discharge, 2006 TransplantsTable 1.9b (31 k)
1.9cImmunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2005 TransplantsTable 1.9c (31 k)
1.10Transplant Recipient Characteristics, 1997 to 2006Table 1.10 (36 k)
Blood Type
Residency
Gender
Race
Age
Previous Transplant Any Organ
Payment Source
1.11aOne Year Adjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005Table 1.11a (31 k)
1.11bOne Year Unadjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005Table 1.11b (31 k)
1.12aOne Year Adjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005Table 1.12a (31 k)
1.12bOne Year Unadjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005Table 1.12b (31 k)
1.13Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival RatesTable 1.13 (37 k)
Standard Errors of the Survival Rates
Survival (%)
Number of Transplants For This Survival Analysis
1.14Prevalence of People Living with a Functioning Transplant at End of Year 1997 to 2005Table 1.14 (20 k)

Section II

2.1Deceased Donor Characteristics, 1997 to 2006 Deceased Donors of Any OrganTable 2.1 (45 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.2Deceased Donor Characteristics, 1997 to 2006 Kidney DonorsTable 2.2 (47 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
Donor Type
2.3Deceased Donor Characteristics, 1997 to 2006 Pancreas DonorsTable 2.3 (44 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.4Deceased Donor Characteristics, 1997 to 2006 Liver DonorsTable 2.4 (45 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.5Deceased Donor Characteristics, 1997 to 2006 Intestine DonorsTable 2.5 (44 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.6Deceased Donor Characteristics, 1997 to 2006 Heart DonorsTable 2.6 (44 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
2.7Deceased Donor Characteristics, 1997 to 2006 Lung DonorsTable 2.7 (44 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.8Living Donor Characteristics, 1997 to 2006 Living Donors of Any OrganTable 2.8 (35 k)
Age
Blood Type
Gender
Race
Donor Relation
2.9Living Donor Characteristics, 1997 to 2006 Kidney DonorsTable 2.9 (35 k)
Age
Blood Type
Gender
Race
Donor Relation
2.10Living Donor Characteristics, 1997 to 2006 Liver Segment DonorsTable 2.10 (34 k)
Age
Blood Type
Gender
Race
Donor Relation
2.11Living Donor Characteristics, 1997 to 2006 Lung Lobe DonorsTable 2.11 (34 k)
Age
Blood Type
Gender
Race
Donor Relation
2.12Deceased Donor Organ Utilization, 1997 to 2006, Any OrganTable 2.12 (32 k)
2.13Deceased Donor Organ Utilization, 1997 to 2006, KidneyTable 2.13 (37 k)
2.14Deceased Donor Organ Utilization, 1997 to 2006, PancreasTable 2.14 (36 k)
2.15Deceased Donor Organ Utilization, 1997 to 2006, LiverTable 2.15 (36 k)
2.16Deceased Donor Organ Utilization, 1997 to 2006, IntestineTable 2.16 (36 k)
2.17Deceased Donor Organ Utilization, 1997 to 2006, HeartTable 2.17 (36 k)
2.18Deceased Donor Organ Utilization, 1997 to 2006, LungTable 2.18 (36 k)

Section III

3.1Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 KidneyTable 3.1 (27 k)
3.2Reasons for Non-Use of Recovered Organs, 1997 to 2006 KidneyTable 3.2 (30 k)
3.3Reasons for Non-Recovery of Consented Organs, 1997 to 2006 KidneyTable 3.3 (29 k)
3.4Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 PancreasTable 3.4 (27 k)
3.5Reasons for Non-Use of Recovered Organs, 1997 to 2006 PancreasTable 3.5 (30 k)
3.6Reasons for Non-Recovery of Consented Organs, 1997 to 2006 PancreasTable 3.6 (29 k)
3.7Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 LiverTable 3.7 (28 k)
3.8Reasons for Non-Use of Recovered Organs, 1997 to 2006 LiverTable 3.8 (29 k)
3.9Reasons for Non-Recovery of Consented Organs, 1997 to 2006 LiverTable 3.9 (29 k)
3.10Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 IntestineTable 3.10 (26 k)
3.11Reasons for Non-Use of Recovered Organs, 1997 to 2006 IntestineTable 3.11 (29 k)
3.12Reasons for Non-Recovery of Consented Organs, 1997 to 2006 IntestineTable 3.12 (29 k)
3.13Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 HeartTable 3.13 (27 k)
3.14Reasons for Non-Use of Recovered Organs, 1997 to 2006 HeartTable 3.14 (29 k)
3.15Reasons for Non-Recovery of Consented Organs, 1997 to 2006 HeartTable 3.15 (29 k)
3.16Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 LungTable 3.16 (27 k)
3.17Reasons for Non-Use of Recovered Organs, 1997 to 2006 LungTable 3.17 (29 k)
3.18Reasons for Non-Recovery of Consented Organs, 1997 to 2006 LungTable 3.18 (29 k)

Section IV

4.1Deceased Donors Procured by U.S. Organ Procurement Organizations 1997 to 2006Table 4.1 (47 k)
4.2Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2007, By Home State of OPOTable 4.2 (67 k)

Section V

5.1aWaiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1997 to 2006Table 5.1a (44 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
PRA
Previous Transplant Same Organ
Time on Waiting List
5.1bWaiting List Patient Characteristics at End of Year Kidney Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 5.1b (38 k)
Age
Diagnosis
Gender
Race
Time on Waiting List
5.2Time to Transplant, 1997 to 2006 New Kidney Waiting List RegistrationsTable 5.2 (98 k)
Blood Type
Age
Gender
All Patient Types
PRA
Gender and PRA
Race and PRA
Previous Transplant Any Organ
Previous Transplant and Gender
Previous Transplant and PRA
Previous Transplant and Race
Race
Residency
5.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Kidney Waiting ListTable 5.3 (50 k)
Age
Blood Type
Diagnosis
Gender
Race
5.4Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor KidneysTable 5.4 (28 k)
5.4aTransplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor non-ECD KidneysTable 5.4a (57 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4bTransplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Expanded Criteria Donors (ECD) KidneysTable 5.4b (56 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4cTransplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor KidneysTable 5.4c (55 k)
Age
Blood Type
Residency
Gender
PRA
Race
Donor Relation
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.5Incidence of Transplant, 1997 to 2006 Kidney Transplants per 1 Million PopulationTable 5.5 (29 k)
5.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Kidney TransplantsTable 5.6a (29 k)
5.6bImmunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Kidney TransplantsTable 5.6b (31 k)
5.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Kidney TransplantsTable 5.6c (29 k)
5.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Kidney TransplantsTable 5.6d (30 k)
5.6eImmunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Kidney TransplantsTable 5.6e (31 k)
5.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Kidney TransplantsTable 5.6f (31 k)
5.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Kidney TransplantsTable 5.6g (31 k)
5.6hPersistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Kidney TransplantsTable 5.6h (34 k)
5.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Kidney TransplantsTable 5.6i (30 k)
5.7aPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney TransplantationTable 5.7a (89 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Previous Transplant Any Organ
Diagnosis
5.7bPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor ECD Kidney TransplantationTable 5.7b (85 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Previous Transplant Any Organ
Diagnosis
5.7cPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Kidney TransplantationTable 5.7c (78 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Age
Hospitalized at Tx
Level of HLA Mismatch
Previous Transplant Any Organ
Diagnosis
5.8aAdjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.8a (39 k)
Age
Gender
Race
Diagnosis
5.8bAdjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.8b (38 k)
Age
Gender
Race
Diagnosis
5.8cAdjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.8c (38 k)
Age
Gender
Race
Diagnosis
5.9aAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.9a (22 k)
5.9bAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.9b (23 k)
5.9cAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney TransplantsTable 5.9c (22 k)
5.10aUnadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.10a (49 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.10bUnadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.10b (48 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.10cUnadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.10c (49 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.11aUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.11a (23 k)
5.11bUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.11b (23 k)
5.11cUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney TransplantsTable 5.11c (22 k)
5.12aAdjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.12a (38 k)
Age
Gender
Race
Diagnosis
5.12bAdjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.12b (38 k)
Age
Gender
Race
Diagnosis
5.12cAdjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.12c (37 k)
Age
Gender
Race
Diagnosis
5.13aAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.13a (22 k)
5.13bAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.13b (23 k)
5.13cAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney TransplantsTable 5.13c (22 k)
5.14aUnadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.14a (48 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.14bUnadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.14b (48 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.14cUnadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 5.14c (48 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
5.15aUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.15a (22 k)
5.15bUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.15b (23 k)
5.15cUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney TransplantsTable 5.15c (22 k)
5.16Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1997 to 2005Table 5.16 (48 k)
Blood Type
Residency
Gender
PRA
Race
Donor Type
Age
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
5.17Transplants by State and Transplant Center, 1997 to 2006 KidneyTable 5.17 (95 k)

Section VI

6.1aWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1997 to 2006Table 6.1a (38 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.1bWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 6.1b (33 k)
Age
Gender
Race
Time on Waiting List
6.2Time to Transplant, 1997 to 2006 New Pancreas Transplant Alone (PTA) Waiting List RegistrationsTable 6.2 (55 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
6.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas Transplant Alone (PTA) Waiting ListTable 6.3 (40 k)
Age
Blood Type
Gender
Race
6.4Transplant Recipient Characteristics, 1997 to 2006 Pancreas Transplant Alone (PTA) RecipientsTable 6.4 (39 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
6.5Incidence of Transplant, 1997 to 2006 Pancreas Transplant Alone (PTA) Transplants per 1 Million PopulationTable 6.5 (29 k)
6.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6a (29 k)
6.6bImmunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6b (31 k)
6.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6c (29 k)
6.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6d (30 k)
6.6eImmunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6e (30 k)
6.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6f (31 k)
6.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6g (31 k)
6.6hPersistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6h (33 k)
6.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6i (30 k)
6.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) TransplantationTable 6.7 (66 k)
Blood Type
Residency
Gender
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Previous Transplant Any Organ
6.8Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.8 (30 k)
Age
Gender
Race
6.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.9 (22 k)
6.10Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.10 (37 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
6.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.11 (22 k)
6.12Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.12 (30 k)
Age
Gender
Race
6.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.13 (22 k)
6.14Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 6.14 (37 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
6.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.15 (22 k)
6.16Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1997 to 2005Table 6.16 (37 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
6.17Transplants by State and Transplant Center, 1997 to 2006 Pancreas Transplant Alone (PTA)Table 6.17 (54 k)

Section VII

7.1aWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1997 to 2006Table 7.1a (37 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.1bWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 7.1b (33 k)
Age
Gender
Race
Time on Waiting List
7.2Time to Transplant, 1997 to 2006 New Pancreas After Kidney (PAK) Waiting List RegistrationsTable 7.2 (49 k)
Blood Type
Age
Gender
All Patient Types
Race
Residency
7.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas After Kidney (PAK) Waiting ListTable 7.3 (39 k)
Age
Blood Type
Gender
Race
7.4Transplant Recipient Characteristics, 1997 to 2006 Pancreas After Kidney (PAK) RecipientsTable 7.4 (39 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Payment Source
7.5Incidence of Transplant, 1997 to 2006 Pancreas After Kidney (PAK) Transplants per 1 Million PopulationTable 7.5 (29 k)
7.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6a (29 k)
7.6bImmunosuppression Use for Induct